tiprankstipranks
Trending News
More News >
Bunge Global (BG)
NYSE:BG

Bunge Global (BG) AI Stock Analysis

Compare
1,518 Followers

Top Page

BG

Bunge Global

(NYSE:BG)

Select Model
Select Model
Select Model
Neutral 64 (OpenAI - 5.2)
Rating:64Neutral
Price Target:
$125.00
▲(2.98% Upside)
Action:DowngradedDate:02/05/26
The score is held back primarily by weaker profitability, compressed margins, and a meaningful 2025 leverage step-up with volatile cash conversion. Offsetting this are strong bullish price momentum and a constructive earnings outlook driven by Viterra integration and synergy delivery, though valuation looks only fair and near-term visibility is constrained by policy and cadence risks.
Positive Factors
Viterra combination and integration
Completing the Viterra deal creates a materially larger origination and processing footprint, improving supply-chain connectivity and diversification. These structural advantages support compounding revenue opportunities, scale economies, and sustained synergy capture that can boost long-term competitive positioning.
Diversified global agribusiness value chain
Bunge's presence across oilseeds, grains, fertilizer, processing and trading provides durable revenue diversification and natural hedges across geographies and product cycles. This broad, integrated model reduces single-market exposure and supports steadier long-term cash flow versus pure-play commodity peers.
Strong cash generation and liquidity position
Consistent adjusted funds from operations, positive free cash flow coverage of net income, and large unused committed facilities provide financial flexibility for capex, buybacks, and debt servicing. This cash profile supports strategic investments and cushions cyclical downturns.
Negative Factors
Marked increase in leverage after acquisition
The near-doubling of reported total debt materially raises financial risk and interest exposure, reducing balance-sheet flexibility. Higher leverage constrains capital allocation choices, elevates refinancing risk through economic cycles, and increases sensitivity to commodity-driven cashflow volatility.
Compressed margins and weaker reported profitability
Despite revenue scale, persistent margin compression indicates structural pressure from commodity spreads, integration costs, and timing effects. Lower sustainable margins reduce earnings power and free cash generation per dollar of revenue, limiting long-term returns absent structural cost or premium product improvements.
Policy uncertainty and project timing risk
Unresolved regulatory drivers (notably RVO biofuel policy) and delayed project contributions create multi-quarter earnings cadence risk. Structural policy shifts and slow ramp of greenfield projects can mute expected synergies and returns, increasing execution risk and earnings volatility over the medium term.

Bunge Global (BG) vs. SPDR S&P 500 ETF (SPY)

Bunge Global Business Overview & Revenue Model

Company DescriptionBunge Limited operates as an agribusiness and food company worldwide. It operates through four segments: Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy. The Agribusiness segment purchases, stores, transports, processes, and sells agricultural commodities and commodity products, including oilseeds primarily soybeans, rapeseed, canola, and sunflower seeds, as well as grains primarily wheat and corn; and processes oilseeds into vegetable oils and protein meals. This segment offers its products for animal feed manufacturers, livestock producers, wheat and corn millers, and other oilseed processors, as well as third-party edible oil processing and biofuel companies; and for industrial and biodiesel production applications. The Refined and Specialty Oils segment sells packaged and bulk oils and fats that include cooking oils, shortenings, margarines, mayonnaise, and other products for baked goods companies, snack food producers, confectioners, restaurant chains, foodservice operators, infant nutrition companies, and other food manufacturers, as well as grocery chains, wholesalers, distributors, and other retailers. The Milling segment provides wheat flours and bakery mixes; corn milling products that comprise dry-milled corn meals and flours, wet-milled masa and flours, and flaking and brewer's grits, as well as soy-fortified corn meal, corn-soy blends, and other products; whole grain and fiber ingredients; quinoas and millets; die-cut pellets; and non-GMO products. The Sugar and Bioenergy segment produces sugar and ethanol; and generates electricity from burning sugarcane bagasse. Bunge Limited was founded in 1818 and is headquartered in St. Louis, Missouri.
How the Company Makes MoneyBunge Global generates revenue through multiple key streams within its agribusiness operations. The primary revenue sources include the sale of processed agricultural products, such as oils and meal from oilseeds, and grain trading. The company also earns income from its fertilizer business, which involves the production and distribution of crop nutrients to farmers. Additionally, BG benefits from global commodity trading and has established significant partnerships with farmers and food manufacturers, allowing for efficient supply chain management and operational synergies. The company’s expansive global network and diversified product offerings help mitigate risks and stabilize earnings across different market conditions.

Bunge Global Key Performance Indicators (KPIs)

Any
Any
Soybeans Processed Volumes
Soybeans Processed Volumes
Chart Insights
Data provided by:The Fly

Bunge Global Earnings Call Summary

Earnings Call Date:Feb 04, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Apr 29, 2026
Earnings Call Sentiment Positive
The call described strong strategic progress — completion of the Viterra combination, significant adjusted EBIT growth, ahead-of-plan synergies, solid cash generation and liquidity, and a constructive multi-year outlook — but was tempered by a steep drop in reported EPS driven by one-time notable items and mark-to-market timing, modest adjusted EPS decline, a light Q1 cadence, and meaningful policy uncertainty (notably U.S. RVO/biofuel). Overall the company presented durable operational improvements and financial flexibility while acknowledging near-term timing and policy headwinds.
Q4-2025 Updates
Positive Updates
Completion and Integration of Viterra
Major milestone reached with completion of the Viterra combination; integration delivering increased connectivity, expanded origination/processing footprint, and improved coordination across origin and destination — management expects durable, compounding benefits and will provide further details at Investor Day (March 10).
Adjusted EBIT Growth
Adjusted segment EBIT of $756 million in Q4 versus $546 million prior year — an increase of $210 million, or ~38.5% year-over-year, with all segments showing higher results.
Synergies Ahead of Schedule
Realized synergies of just over $70 million in 2025; management is guiding approximately $190 million of realized synergies in 2026 with a run-rate of ~$220 million by year-end (cost synergies primarily baked into guidance).
Strong cash generation and liquidity
Generated ~ $1.7 billion adjusted funds from operations for the year and ~$1.25 billion discretionary cash flow; year-end committed credit facilities ~$9.7 billion with ~ $9.0 billion unused; retained cash flow ~$173 million after dividends, growth CapEx, and buybacks.
Capital return and investment activity
Returned capital via $459 million in dividends and repurchased 6.7 million shares for $551 million; invested ~$1.2 billion in growth and productivity CapEx while allocating $485 million to sustaining CapEx.
Forward guidance and financial targets
Management forecasted full-year 2026 adjusted EPS of $7.50–$8.00; provided guidance ranges including adjusted effective tax rate 23–27%, net interest expense $575–$620 million, CapEx $1.5–$1.7 billion, and depreciation & amortization ~ $975 million; trailing 12-month adjusted ROIC 8.1% (9.3% when adjusted for projects/excess cash) and cash return on equity 9.4% vs cost of equity 7.2%.
Negative Updates
Large decline in reported EPS
Reported Q4 EPS was $0.49 versus $4.36 in Q4 2024, a drop of ~$3.87 per share (~-88.7%). Management attributed much of the decline to an unfavorable mark-to-market timing difference of $0.55 per share and notable items (~$0.95) including U.S. defined benefit pension settlement, Viterra integration costs, and an impairment.
Adjusted EPS modest decline
Adjusted EPS fell to $1.99 in Q4 from $2.13 a year ago — a decline of $0.14 or ~-6.6% year-over-year despite higher adjusted EBIT, reflecting one-time items, timing effects, and tax benefits (~$50 million of net tax benefits included in the quarter).
Short-term visibility and policy uncertainty (RVO/biofuel)
Management cited limited forward visibility driven by geopolitical tensions, evolving trade flows and uncertainty around U.S. biofuel (RVO) policy; biofuel timing/details are a material swing factor and remain unresolved, increasing short-term earnings cadence risk.
Earnings cadence skewed to back half
Guidance assumes a back-half weighted year (management noted a 30/70 first-half/second-half split for the year and ~35/65 split for H1), implying a very light Q1; this front-loaded uncertainty contributed to lower near-term EPS expectations versus some sell‑side models.
Higher interest and acquisition-related financial headwinds
Net interest expense rose to $176 million in the quarter (increase vs prior year) reflecting debt assumed/issued for Viterra; year-end net debt (excluding readily marketable inventories) was ~ $700 million and adjusted leverage was 1.9x, reflecting acquisition-related leverage.
Delayed contribution from large projects and regional softness
Several large greenfield/multiyear projects are in commissioning or completion phases (e.g., Moorestown, Destrehan, West Sun) with limited contribution baked into 2026; regional weaknesses noted (lower North America processing/refining results and some European refining softness) and certain merchandizing/milling subsegments remain challenged.
Company Guidance
Bunge guided full-year 2026 adjusted EPS of $7.50–$8.00, saying the outlook is based on current forward curves (no assumed RVO change) and expects a back‑half weighting roughly 30%/70% (with Q1 light and a ~35%/65% Q1/Q2 split for the first half); key planning metrics include an adjusted annual effective tax rate of 23%–27%, net interest expense of $575–$620 million, capital expenditures of $1.5–$1.7 billion, and depreciation & amortization of ~ $975 million. Management baked about $190 million of realized synergies into 2026 (>$70M realized in 2025, ~ $220M run‑rate by year‑end), and referenced prior-year operating cash/returns: adjusted funds from operations of just over $1.7 billion, sustaining CapEx of $485 million, discretionary cash flow of ~$1.25 billion, $459 million of dividends, $1.2 billion of growth/productivity CapEx, ~$1.2 billion of asset sale proceeds, 6.7 million shares repurchased for $551 million, $173 million retained cash flow, year‑end net debt excluding RMI of ~ $700 million, adjusted leverage ~1.9x, committed credit facilities of ~$9.7 billion with ~$9.0 billion unused, and trailing‑12‑month adjusted ROIC of 8.1% (ROIC 6.9%; adjusted ROIC w/ projects/excess cash ~9.3%, ROIC ~7.5%).

Bunge Global Financial Statement Overview

Summary
Top-line rebounded in 2025, but profitability weakened materially versus 2023–2024 with net margin compressing to ~1.2%. Balance sheet risk increased as total debt nearly doubled in 2025, reducing flexibility. Cash flow is positive and free cash flow covered net income in 2025, but operating cash flow has been volatile and below prior-year levels.
Income Statement
62
Positive
Revenue rebounded strongly in 2025 (up ~17% to $70.3B after a down 2023–2024), but profitability has weakened versus prior years. Net income fell to $0.82B in 2025 from $1.14B in 2024 and $2.24B in 2023, and margins compressed meaningfully (net margin ~1.2% in 2025 vs ~2.1% in 2024 and ~3.8% in 2023). Overall, solid top-line scale and recovery, offset by clear margin pressure and a lower earnings run-rate.
Balance Sheet
48
Neutral
Leverage increased sharply in 2025: total debt rose to $13.8B from $7.1B in 2024 while equity expanded to $17.4B, alongside a large jump in total assets to $44.5B. While the larger equity base helps, the step-up in debt raises financial risk and reduces balance sheet flexibility versus the prior 2–3 years when leverage looked more moderate.
Cash Flow
54
Neutral
Cash generation is mixed and somewhat volatile. Operating cash flow improved to $0.84B in 2025 (positive) but is down from $1.9B in 2024 and well below $3.3B in 2023; earlier years (2020–2022) saw sizable negative operating cash flow. Free cash flow was positive at $0.84B in 2025 and covered net income about 1.0x, but the overall pattern suggests working-capital swings and less consistent cash conversion than ideal.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue70.33B53.11B59.54B67.23B59.15B
Gross Profit3.41B3.39B4.84B3.68B3.36B
EBITDA2.46B2.46B4.02B2.88B3.23B
Net Income816.00M1.14B2.24B1.61B2.08B
Balance Sheet
Total Assets44.53B24.90B25.37B24.58B23.82B
Cash, Cash Equivalents and Short-Term Investments1.34B3.79B2.71B1.22B1.42B
Total Debt16.95B7.12B5.76B5.62B6.82B
Total Liabilities27.11B13.95B13.56B14.62B15.61B
Stockholders Equity17.37B9.91B10.85B9.22B7.67B
Cash Flow
Free Cash Flow-923.00M524.00M2.19B-6.10B-3.29B
Operating Cash Flow800.00M1.90B3.31B-5.55B-2.89B
Investing Cash Flow-5.04B-1.11B-1.01B6.50B5.11B
Financing Cash Flow2.07B-90.00M-856.00M-769.00M-1.63B

Bunge Global Technical Analysis

Technical Analysis Sentiment
Positive
Last Price121.38
Price Trends
50DMA
106.14
Positive
100DMA
98.99
Positive
200DMA
88.75
Positive
Market Momentum
MACD
4.37
Positive
RSI
66.97
Neutral
STOCH
56.63
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BG, the sentiment is Positive. The current price of 121.38 is above the 20-day moving average (MA) of 118.56, above the 50-day MA of 106.14, and above the 200-day MA of 88.75, indicating a bullish trend. The MACD of 4.37 indicates Positive momentum. The RSI at 66.97 is Neutral, neither overbought nor oversold. The STOCH value of 56.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BG.

Bunge Global Risk Analysis

Bunge Global disclosed 41 risk factors in its most recent earnings report. Bunge Global reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Bunge Global Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
$9.98B11.4314.44%4.44%
73
Outperform
$4.04B3.5948.69%10.53%65.80%197.95%
70
Outperform
$2.01B22.564.53%3.34%1.11%414.23%
64
Neutral
$23.71B24.906.34%3.14%10.29%17.32%
64
Neutral
$32.73B30.544.80%3.55%-4.31%-29.96%
63
Neutral
$21.88B110.911.10%3.48%2.12%-40.75%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
BG
Bunge Global
121.38
50.31
70.80%
ADM
Archer Daniels Midland
67.45
22.07
48.64%
CALM
Cal-Maine Foods
84.43
3.56
4.40%
FDP
Fresh Del Monte Produce
42.23
13.31
46.02%
TSN
Tyson Foods
62.61
4.38
7.53%
SFD
Smithfield Foods
24.53
4.84
24.58%

Bunge Global Corporate Events

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Bunge Global Reduces Share Capital and Updates Governance
Neutral
Dec 19, 2025

Effective December 16, 2025, Bunge Global SA reduced its share capital by USD 123,826.10, from USD 2,208,943.73 to USD 2,085,117.63, following the cancellation of 12,382,610 repurchased registered shares with a nominal value of $0.01 per share as part of its share repurchase program. In connection with this capital reduction, the company also amended Article 4a of its Articles of Association to update its Swiss capital band provision, formalizing the changes to its equity structure and governance framework.

The most recent analyst rating on (BG) stock is a Buy with a $120.00 price target. To see the full list of analyst forecasts on Bunge Global stock, see the BG Stock Forecast page.

Executive/Board Changes
Bunge Global Announces Leadership Change in COO Role
Neutral
Dec 12, 2025

On December 12, 2025, Bunge Global SA announced the departure of David Mattiske from his role as co-Chief Operating Officer to explore other professional opportunities. Julio Garros, currently serving as co-Chief Operating Officer, will take over as Chief Operating Officer starting December 12, 2025, ensuring a smooth transition of responsibilities.

The most recent analyst rating on (BG) stock is a Hold with a $99.00 price target. To see the full list of analyst forecasts on Bunge Global stock, see the BG Stock Forecast page.

Financial DisclosuresRegulatory Filings and Compliance
Bunge Global Reports New Financial Obligation
Neutral
Dec 12, 2025

Bunge Global has released a current report on Form 8-K, which is a standard form used by publicly traded companies to disclose significant events that shareholders should know about. The report’s content, however, is not detailed in the provided text, leaving the specific impact on Bunge Global’s operations, industry positioning, or implications for stakeholders unclear.

The most recent analyst rating on (BG) stock is a Hold with a $99.00 price target. To see the full list of analyst forecasts on Bunge Global stock, see the BG Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 05, 2026